AbbVie, Inc. v. Teva Pharmaceuticals, Inc.
| AbbVie Inc. |
| Teva Pharmaceuticals Industries Ltd. and Teva Pharmaceuticals, Inc. |
| 1:2023cv00374 |
| April 3, 2023 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 19, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 8
SO ORDERED Granting #7 Stipulation and Proposed Order (*Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 7/3/2023). Signed by Judge Richard G. Andrews on 5/19/2023. (nms)
|
| Filing 7 STIPULATION and [Proposed] Order Regarding Teva Defendants by AbbVie Inc.. (Tigan, Jeremy) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin - filed by AbbVie Inc.. (Tigan, Jeremy) |
|
SO ORDERED, re (D.I. 6 in 23-cv-470-RGA; D.I. 6 in 23-cv-374-RGA; D.I. 6 in 23-cv-448-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jennifer H. Roscetti, Danielle A. Duszczyszyn, William B. Raich, Constance P. Lee, Ryan V. McDonnell and Reinaldo Franqui Machin, filed by AbbVie Inc.. Signed by Judge Richard G. Andrews on 5/4/2023. Associated Cases: 1:23-cv-00374-RGA, 1:23-cv-00448-RGA, 1:23-cv-00470-RGA(nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00362-RGA, 1:23-cv-00374-RGA (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/21/2023. Date of Expiration of Patent: 07/29/2039.Thirty Month Stay Deadline: 1/23/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-4104067.) - filed by AbbVie Inc.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
| No Summons Issued. (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
